Business
Press Release May 18 2026
Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 18, 2026, titled "Strides Delivers Strong Performance with FY26 EBITDA at ₹9,253m, Operational PAT at ₹5,181m, 50% YoY Growth".
About this update from Strides Pharma Science Ltd
[{"type":"text","content":" Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 18, 2026, titled \"Strides Delivers Strong Performance with FY26 EBITDA at ₹9,253m, Operational PAT at ₹5,181m, 50% YoY Growth\". View Attachment","length":390,"tagName":"div"}]